All Lawsuits
Open Healthcare

GSK Boostrix 'Big Bad Cough' Misleading Advertising Settlement

vs. GlaxoSmithKline PLC

Est. Payout
10 - 50 dollars
Deadline
Jun 8, 2026
Views
6
Summary

GlaxoSmithKline settled claims that its 'Big Bad Cough' advertising campaign misled consumers about the Boostrix vaccine's effectiveness in preventing whooping cough transmission. The settlement covers individuals who viewed the ads and lived in or received the vaccine in New York between 2016-2020.

Details
The lawsuit alleged that GSK's 'Big Bad Cough' campaign, which ran from 2015 to 2020 and featured humanized wolves, made false claims about Boostrix's ability to prevent whooping cough from spreading to others. Plaintiffs argued they would not have purchased the tetanus, diphtheria and whooping cough vaccine if they had known the truth about its limitations. Class members can receive compensation based on whether they have documentation of their vaccination.
Who's Eligible?

Adults who viewed the 'Big Bad Cough' advertising campaign and either lived in New York or were vaccinated with Boostrix in New York between May 20, 2016, and May 20, 2020

File Your Claim